Hypoalbuminemia

Ballmer PE (2001) Causes and mechanisms of hypoalbuminaemia. Clin Nutr 20:271–273 Hawkins JW, Dugaiczyk A (1982) The human serum albumin gene: structure of a unique locus. Gene 19:55–58 Harper ME, Dugaiczyk A (1983) Linkage of the evolutionary-related serum albumin and alpha-protein genes within q11–22 of human chromosome 4. Am J Hum Genet 35:565–572 Minghetti PP, Ruffner DE, Kuang WJ, Dennison OE, Hawkins JW, Beattie WG, Dugaiczyk A (1986) Molecular structure of the human albumin gene is revealed by nucleotide sequence within q11–22 of chromosome 4. J Biol Chem 261:6747–6757 Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P (2012) Human serum albumin: from bench to bedside. Mol Aspects Med 33:209–290 Franch-Arcas G (2001) The meaning of hypoalbuminaemia in clinical practice. Clin Nutr 20:265–269 Nicholson JP, Wolmarans MR, Park GR (2000) The role of albumin in critical illness. Br J Anaesth 85:599–610 Rothschild MA, Oratz M, Schreiber SS (1988) Serum albumin. Hepatology 8(2):385–401 Yamauchi A, Fukuhara Y, Yamamoto S, Yano F, Takenaka M, Imai E, Nogichi T, Tanaka T, Kamada T, Ueda N (1992) Oncotic pressure regulates gene transcriptions of albumin and apolipoprotein B in cultured rat hepatoma cells. Am J Physiol 263:C397–C404 Herrmann FR, Saqfran C, Levkoff SE, Minaker KL (1992) Serum albumin level on admission as a predictor of death, length of stay and readmission. Arch Intern Med 152:125–130 Studer R, Potchen J (1971) The radioisotopic assessment of regional microvascular permeability to macromolecules. Microvasc Res 3:35–48 Boldt J (2010) Use of albumin: an update. Br J Anaesth 104:276–284 Ganong WF (1995) Dynamics of blood and lymph flow. In: Ganong WF (ed) Review of medical physiology, 17th edn. Apple & Lange, EastNorwalk, pp 525–541 Rothuizen J (2009) Important clinical syndromes associated with liver disease. Vet Clin North Am Small Anim Pract 39:419–437 Doweiko JP, Nompleggi DJ (1991) Role of albumin in human physiology and pathophysiology. J Parent Enteral Nutr 15:207–211 Vorobey P, Steindal AE, Off MK, Vorobey A, Moan J (2006) Influence of human serum albumin on photodegradation of folic acid in solution. Photochem Photobiol 82:817–822 Curry S (2009) Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Drug Metab Pharmacokinet 24:342–357 Bernardi M, Caraceni P, Nivickis RJ, Wilkes MM (2012) Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology 55:1172–1181 Wauters J, Wilmer A (2011) Albumin dialysis: current practice and future options. Liver Int 31(Suppl. 3):9–12 Nevens F, Laleman W (2012) Artificial liver support devices as treatment option for liver failure. Best Pract Res Clin Gastroenterol 26:17–26 Goldwasser P, Feldman J (1997) Association of serum albumin and mortality risk. J Clin Epidemiol 50:693–703 Gibbs J, Cull W, Henderson W, Doley J, Hur K, Fhuri SF (1999) Preoperative serum albumin level as a predictor of mortality and morbidity. Arch Surg 134:36–42 Moshage HJ, Janssen J, Franssen JH, Hafkenscheid JCM, Yap SH (1987) Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest 79:1635–1641 Allison SP, Lobo DN, Stanga Z (2001) The treatment of hypoalbuminaemia. Clin Nutr 20:275–279 Woodcock TE (2012) Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 108:384–394. doi:10.1093/bja/aer515 Ballmer PE, Ochsenbein AF, Schutz-Hofmann S (1994) Transcapillary escape rate of albumin positively correlates with plasma albumin concentration in acute but not in chronic inflammatory disease. Metabolism 43:697–705 Boldt J (2000) The good, the bad, and the ugly: should we completely banish human albumin from our intensive care units? Anesth Analg 91:887–895 Parving HH, Ranek L, Lassen NA (1977) Increased transcapillary escape rate of albumin in patients with cirrhosis of the liver. Scand J Clin Lab Invest 37:643–648 Sitges-Serra A (2001) Introduction to the Symposium on hypoalbuminaemia. Clin Nutr 20:263–264 Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM (2003) Hypoalbuminaemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 237:319–334 Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossettias G (2009) Recommendations for the use of albumin and immunoglobulins. Blood Transfus 7:216–234. doi:10.2450/2009.0094-09 Anderson P, Bunn F, Li Wan Po A, Li L, Blackhall K, Roberts I, Schierhout G (2011) Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 10: CD001208. Update in: Cochrane Database Syst Rev (2011) 11: CD001208 Dellinger RP et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 36:296–327 Gines P, Fernandez J, Durand F, Saliba F (2012) Management of critically-ill cirrhotic patients. J Hepatol 56(Suppl 1):S13–S24 Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256 Finfer S, Bellomo R, McEvoy S, Lo SK, Myburgh J, Neal B, Norton R (2006) Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 333:1044–1046 Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R (2011) Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 37:86–96 SAFE Study Investigator, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood Service, George Institute for International Health, Myburgh J, Cooper DJ, Finfer S, Bellomo R, Norton R, Bishop N, Kai Lo S, Vallance S (2007) Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 357:874–884 Delaney AP, Dan A, McCaffrey J, Finfer S (2011) The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 39:386–391 Lasky LC, Finnerty EP, Genis L, Polesky HF (1984) Protein and colloid osmotic pressure changes with albumin and/or saline replacement during plasma exchange. Transfusion 24:256–259 Quillen K, Berkman EM (2003) Introduction to therapeutic apheresis. In: McLeod BC, Price TH, Weinstein R (eds) Apheresis: principles and practice, 2nd edn. AABB Press, Bethesda, pp 49–69 Crookston K, Simon TL (2003) Physiology of apheresis. In: McLeod BC, Price TH, Weinstein R (eds) Apheresis: principles and practice, 2nd edn. AABB Press, Bethesda, pp 71–93 Bunn F, Trivedi D, Ashraf S (2011) Colloid solutions for resuscitation. Cochrane Database Syst Rev 16:CD001319 Boldt J (2010) Safety of nonblood plasma substitutes: less frequently discussed issues. Eur J Anaesthesiol 27:495–500 Vincent JL, Navickis RJ, Wilkes MM (2004) Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 32:2029–2038 Dharmaraj R, Hari P, Bagga A (2009) Randomized cross-over trial comparing albumin and furosemide infusions in nephrotic syndrome. Pediats Nephrol 24:775–782 Elwell RJ, Spencer AP, Eisele G (2003) Combined furosemide and human albumin treatment for diuretic-resistant edema. Ann Pharmacother 37:695–700 Gore DC, Dalton JM, Gehr TW (1996) Colloid infusions reduce glomerular filtration in resuscitated burn victims. J Trauma 40:356–360 Angeli P, Gatta A (2005) L’efficacia dell’albumina nell’insufficienza epatica. Minerva Anestesiol 71:17–26 Ginès P (2010) EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome. J Hepatol 53:397–417 Ginès P, Cardenas A, Arroyo V, Rodes J (2004) Management of cirrhosis and ascites. N Engl J Med 350:1646–1654 Ginès A, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, Angeli P, Ruiz-Del-Arbol L, Planas R, Solà R, Ginès P, Terg R, Inglada L, Vaque P, Salerno F, Vargas V, Clemente G, Quer JC, Jimenez W, Arroyo V, Rodes J (1996) Randomized trial comparing albumin, Dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 111:1002–1010 Planas R, Gines P, Arroyo V, Llach J, Panes J, Vargas V, Salmeron JM, Gines A, Toledo C, Rimola A, Jimenez W, Asbert M, Gassull MA, Rodes J (1990) Dextran-70 vs. albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology 99:1736–1744 Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-Del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341:403–409 Runyon BA (1999) Albumin infusion for spontaneous bacterial peritonitis. Lancet 354:1838–1839 Wong F, Bernardi M, Balk R, Christman B, Moreau R, Gascia-Tsao G, Patch D, Soriano G, Hoefs J, Navasa M, International Ascites Club (2005) Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 54:718–7251 Fernandez J, Monteagudo J, Bargallo X, Jimenez W, Bosch J, Arroyo V, Navasa M (2005) Randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology 42:627–634 Wong F (2005) Volume expanders for spontaneous bacterial peritonitis: are we comparing oranges with oranges? Hepatology 42:533–535 Fernandez J, Gustot T (2012) Management of bacterial infections in cirrhosis. J Hepatol 56(Suppl 1):S1–S12 Arroyo V, Terra C, Ginès P (2006) New treatments of hepatorenal syndrome. Semin Liver Dis 26:254–264 Cárdenas A, Ginès P (2006) Therapy insight: management of hepatorenal syndrome. Nat Clin Pract Gastroenterol Hepatol 3:338–348 Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, La Villa G, Laffi G (1999) Albumin improves the response to diuretics in patients with cirrhosis and ascites. Results of a randomized, controlled trial. J Hepatol 30:639–645 Gentilini P, Bernardi M, Bolondi L, Craxi A, Gasbarrini G, Ideo G, Laffi G, La Villa G, Salerno F, Ventura E, Pulazzini A, Segantini L, Romanelli RG (2004) The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. Dig Liver Dis 36:539–546 Moreau R, Valla DC, Durand-Zaleski I, Bronowicki JP, Durand F, Chaput JC, Dadamessi I, Silvain C, Bonny C, Oberti F, Gournay J, Lebrec D, Grouin JM, Guemas E, Golly D, Padrazzi B, Tellier Z (2006) Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trial. Liver Int 26:46–54 Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, Garcia-Tsao G, Lee SS (2010) Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int 30:937–947